Special to TAG-IT News Agency
LONDON - Bridgehead International, the leading strategic healthcare consultancy, has been honored with The Queen's Award for Enterprise 2011, in the International Trade section, for outstanding achievement in international trade.
The Queen's Award for Enterprise is the highest honor that can be bestowed upon a British company and is the UK's top award for business performance. Bridgehead wins the Award for the second time for outstanding achievement in international trade, in recognition of the fact that overseas sales have increased by 146% over a three year period.
Bridgehead CEO, Timothy Fitzgerald said: We are obviously delighted that our business performance merits such a prestigious award. Over the last three years we have continued to build a leading market access consultancy, with expert capabilities and infrastructure in Europe and North America and appropriate strategic partnerships in key emerging markets.
Over the past three years, Bridgehead has sold services to 14 overseas markets. These include the major European markets, the USA and Japan.
Bridgehead is a preferred partner for many leading companies in the pharmaceutical, medical technology and diagnostic sectors, providing a broad range of pricing, reimbursement, health economic and market access support.
imothy Fitzgerald, observed: We have an important role to play, working with commercial organizations, government agencies and the investment community to help life science organizations establish the funding, structure and strategic focus to deliver high levels of innovation and financial return, whilst ensuring patients have rapid and broad access to new innovative medicines, medical devices and diagnostic tools, particularly in areas of high unmet need.
Bridgehead International was established in 1994 to provide independent technical and commercial due diligence support to the biopharmaceutical and financial sectors. The company has grown to become one of the leading global market access consultancies, assisting clients in the development and commercialization of products and services within the pharmaceutical, medical device, diagnostic and related healthcare fields.
With over 50 consultants and 60 associates in Europe, North America, Asia and Latin America, Bridgehead provides a powerful combination of strategic, scientific, commercial, economic and decision support skills and experience.
Bridgehead was previously honored with The Queen's Award for Enterprise in 2007, for outstanding achievement in international trade and in 2009, the company was voted Strategic Healthcare Advisor of the year in the ACQ Finance Magazine Global Awards. For more information about Bridgehead International, please see http://www.bridgehead.com
The Queen's Award scheme was introduced in 1966, originally as The Queen's Award to Industry before becoming known as The Queen's Award for Enterprise in 1999. Her Majesty The Queen makes the awards on the advice of the Prime Minister, who is assisted by an advisory committee that includes representatives of government, industry and commerce, and the trade unions.
login